Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.660
-0.040 (-0.85%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Cytek Biosciences Employees
Cytek Biosciences had 682 employees as of June 30, 2026. The number of employees decreased by 6 or -0.87% compared to the same quarter last year.
Employees
682
Change
-6
Growth
-0.87%
Revenue / Employee
$303,092
Profits / Employee
-$118,150
Market Cap
605.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 682 | -6 | -0.87% | 682 | 0 |
| Mar 31, 2026 | 678 | 15 | 2.26% | 678 | 0 |
| Dec 31, 2025 | 702 | 54 | 8.33% | 702 | 0 |
| Sep 30, 2025 | 692 | 47 | 7.29% | 692 | 0 |
| Jun 30, 2025 | 688 | 43 | 6.67% | 688 | 0 |
| Mar 31, 2025 | 663 | 26 | 4.08% | 663 | 0 |
| Dec 31, 2024 | 648 | -28 | -4.14% | 648 | 0 |
| Sep 30, 2024 | 645 | -43 | -6.25% | 645 | 0 |
| Jun 30, 2024 | 645 | -54 | -7.73% | 645 | 0 |
| Mar 31, 2024 | 637 | -45 | -6.60% | 637 | 0 |
| Dec 31, 2023 | 676 | 93 | 15.95% | 676 | 0 |
| Sep 30, 2023 | 688 | 114 | 19.86% | 688 | 0 |
| Jun 30, 2023 | 699 | 144 | 25.95% | 699 | 0 |
| Mar 31, 2023 | 682 | 171 | 33.46% | 682 | 0 |
| Dec 31, 2022 | 583 | 81 | 16.14% | 583 | 0 |
| Sep 30, 2022 | 574 | 112 | 24.24% | 574 | 0 |
| Jun 30, 2022 | 555 | 126 | 29.37% | 555 | 0 |
| Mar 31, 2022 | 511 | 120 | 30.69% | 511 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Varex Imaging | 2,500 |
| Tactile Systems Technology | 1,086 |
| OrthoPediatrics | 602 |
| SS Innovations International | 483 |
| Cerus | 275 |
| NeuroPace | 220 |
| ClearPoint Neuro | 172 |
CTKB News
- 13 days ago - Cytek Biosciences price target lowered to $5 from $5.50 at Morgan Stanley - TheFly
- 15 days ago - Cytek Biosciences reports Q2 EPS (9c), consensus (2c) - TheFly
- 15 days ago - Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M - TheFly
- 15 days ago - Cytek Biosciences Earnings Call Transcript: Q2 2026 - Transcripts
- 15 days ago - Cytek Biosciences Quarterly report: Q2 2026 - Filings
- 15 days ago - Cytek Biosciences Slides: Q2 2026 - Filings
- 15 days ago - Cytek Biosciences Earnings release: Q2 2026 - Filings
- 15 days ago - Cytek Biosciences Reports Second Quarter 2026 Financial Results - GlobeNewsWire